DLO-FB1-2 dual-labeled probe, 5' FAM/3'

Ended Purchase Order Awarded Last action

Contract number
N3239824P0051
Awardee
Awarding agency
Obligated
$62,965

Award facts

Contract value 100% obligated
$62,965.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Petaluma, CA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00004 · Removal of the UID exemption indicator from clins 0017, 0019, 0021 and 0030 so the invoice can upload in wawf for PO N3239824P0051. See attached conformed… $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 · The purpose of this modification is to include the type of invoice as combo invoice in clause 252.232-7006 wawf payment instructions for PO N3239824P0051. See… $0
Change Order P00001 $0
Original award $62,965

About this award

Written by GovTribe AI ·

The U.S. Bureau of Medicine and Surgery (BUMED) awarded a purchase order to Biosearch Technologies, Inc. for dual-labeled probe products with a firm fixed price ceiling value of $62,965.40. The award, issued on September 11, 2024, with an ultimate completion date of December 31, 2025, represents a modification to Purchase Order N3239824P0051 that removes unique identifier (UID) exemption indicators from four contract line item numbers (CLINs 0017, 0019, 0021, and 0030) to enable invoice upload functionality in the Wide Area Workflow (WAWF) system. No set-aside designation was used in this competitive award.

Biosearch Technologies, Inc., operating through its LGC Biosearch Technologies division and based in Petaluma, California, is a specialized manufacturer of oligonucleotide-based molecular biology tools and laboratory supplies. The company has an established track record as a critical federal supplier, particularly for the Centers for Disease Control and Prevention and BUMED, delivering precision molecular biology components and diagnostic assays used in genetic research, pathogen detection, and public health applications. This award continues the vendor's ongoing support of federal agencies' diagnostic and research capabilities through the supply of advanced laboratory technologies.

Quick answers

Who was awarded contract N3239824P0051?

N3239824P0051 was awarded to Biosearch Technologies, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 11, 2024.

How much is contract N3239824P0051 worth?

The government has obligated $62,965 on N3239824P0051.

Was contract N3239824P0051 competed?

The extent of competition for N3239824P0051 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login